Cargando…
Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic Pain
BACKGROUND: Many aspects of study conduct impact the observed effect size of treatment. Data were utilized from a recently published meta-analysis of randomized, double-blind, placebo-controlled, clinical trials performed for the United States Food and Drug Administration (FDA) approval of full mu-a...
Autores principales: | Meske, Diana S, Vaughn, Ben J, Kopecky, Ernest A, Katz, Nathaniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875508/ https://www.ncbi.nlm.nih.gov/pubmed/31819600 http://dx.doi.org/10.2147/JPR.S201751 |
Ejemplares similares
-
Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials
por: Meske, Diana S, et al.
Publicado: (2018) -
Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone
por: Markman, John, et al.
Publicado: (2018) -
Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial
por: Kopecky, Ernest A., et al.
Publicado: (2017) -
Design and conduct of confirmatory chronic pain clinical trials
por: Katz, Nathaniel
Publicado: (2020) -
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain
por: Markman, John, et al.
Publicado: (2019)